| Literature DB >> 34694726 |
Bashir Ahmad1, Farah Shireen1, Abdur Rauf2, Mohammad Ali Shariati3, Shumaila Bashir4, Seema Patel5, Ajmal Khan6, Maksim Rebezov3,7,8, Muhammad Usman Khan9,10, Mohammad S Mubarak11, Haiyuan Zhang12.
Abstract
Published studies indicate that virtually any kind of botanical material can be exploited to make biocompatible, safe, and cost-effective silver nanoparticles. This hypothesis is supported by the fact that plants possess active bio-ingredients that function as powerful reducing and coating agents for Ag+. In this respect, a phytomediation method provides favourable monodisperse, crystalline, and spherical particles that can be easily purified by ultra-centrifugation. However, the characteristics of the particles depend on the reaction conditions. Optimal reaction conditions observed in different experiments were 70-95 °C and pH 5.5-8.0. Green silver nanoparticles (AgNPs) have remarkable physical, chemical, optical, and biological properties. Research findings revealed the versatility of silver particles, ranging from exploitation in topical antimicrobial ointments to in vivo prosthetic/organ implants. Advances in research on biogenic silver nanoparticles have led to the development of sophisticated optical and electronic materials with improved efficiency in a compact configuration. So far, eco-toxicity of these nanoparticles is a big challenge, and no reliable method to improve the toxicity has been reported. Therefore, there is a need for reliable models to evaluate the effect of these nanoparticles on living organisms.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34694726 PMCID: PMC8675842 DOI: 10.1049/nbt2.12007
Source DB: PubMed Journal: IET Nanobiotechnol ISSN: 1751-8741 Impact factor: 2.050
FIGURE 1Schematic of antimicrobial activity associated with Ag nano‐silver
Summary of the literature on phytofabrication studies, the applied plants along with the targeted applications
| Plants | Plant Part | Size (nm) | Shape | Application | Reference |
|---|---|---|---|---|---|
|
| Fruit | 60.12 | Spherical | Antimicrobial | [ |
|
| Stems, leaves and roots | 175,136,146 | Multiple | N.D | [ |
|
| Shoots | 12 | Spherical | Antibacterial and anticancer | [ |
|
| Leaves | ‐ | ‐ | Antioxidant, antibacterial and antifungal | [ |
|
| Leaves | 35‐55 | Round | Antioxidant, antibacterial, antifungal and anticancer | [ |
|
| Leaves | 3‐37 | Spherical | Medical and pharmaceutical | [ |
|
| Root | 7.3 | Spherical | Antibacterial | [ |
|
| Rhizomes | 10‐15 | Round | Anti‐inflammatory and ant biofilm | [ |
|
| Leaves | 6‐8 | ‐ | Antibacterial | [ |
|
| 80‐‐100 | Spherical | Antimicrobial | [ | |
|
| Seeds | 1‐30 | Spherical | Antibacterial | [ |
|
| Leaves | 15‐50 | Cubic | Cosmetics, foods, and medical | [ |
|
| Leaves | 62 | Spherical rods | Larvicidal | [ |
|
| Leaves | A rane | ‐ | Antibacterial | [ |
| Tarragon | Leaves | 25 | Spherical | Antibacterial | [ |
| Selaginella | Leaves | 5‐10 | Round | Anti, icrobial | [ |
|
| Root | 25‐70 | ‐ | Antibacterial | [ |
|
| Leaves | 6‐45 | Round | Chemotherapy | [ |
|
| Gel | 66.6 | Spherical | Antioxidant | [ |
| Anthoceros | Whole plant | 20‐50 | Cuboidal and triangula | ‐ | [ |
|
| Leaf | 41 | Spherical | Antiplasmodial | [ |
|
| Leaves | 23 | Cubical | Antibacterial | [ |
|
| Leaves | 19 | Multiple | Antibacterial | [ |
|
| Leaves | 7‐23 | Round | Antibacterial/antitumour | [ |
|
| Leaves | 83.7, 5.9,11.8 | Spherical | Antibacterial | [ |
FIGURE 2aAntiviral mechanism of Ag naoparticles impact on HIV‐1 glycoprotein. Ag has the strongest interaction with cys residue
FIGURE 2bColourful table of amino acid residue related to HIV glycoprotein, yellow colour is linked to cycteine residue
FIGURE 3Production of Ag nanoparticle and its effect in two animal models; allergic rhinitis Mouse and Swine
FIGURE 4Schematic medication of wounded area by patch including Ag nanoparticles [223]
FIGURE 5Schematic presentation of an implant surface integrated by Ag nanoparticles and its antimicrobial activity
FIGURE 6Schematic presentation of accumulation of Ag nanoparticles in marine sources and some of their impacts on humans [224]
FIGURE 7Schematic representation of silver nano‐biosensor: stage 1) stabilisation of silver nanoparticles on the surface, stage 2) Bio‐functionalisation of the surface and an increase in refractive index, stage 3) reaction with a ligand analyte and shifting the blue curve to higher wavelength (showing bio‐sensing activity) [225]